Description
Gilteritinib is the salt name for the drug sold under the brand name Xospata. It is an anti-cancer drug used to treat adult patients with relapsed or refractory acute myeloid leukemia (AML) that has an FMS-like tyrosine kinase 3 (FLT3) mutation. It works by inhibiting FLT3 and other tyrosine kinases, which are often mutated in AML and drive cancer cell growth.
On November 28, 2018, the Food and Drug Administration approved gilteritinib (XOSPATA, Astellas Pharma US Inc.) for treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test.
The FDA also approved an expanded indication for a companion diagnostic, to include use with gilteritinib. The LeukoStrat CDx FLT3 Mutation Assay, developed by Invivoscribe Technologies, Inc., is used to detect the FLT3 mutation in patients with AML.
Who is the CFA, distributor, and retailer for Xospata (Gilteritinib) Tablets in India?
Aark Pharmaceuticals is an authorized distributor, CFA (Carry and Forward Agent), and retailer for Xospata (Gilteritinib) Tablets in India. It is marketed by Astellas Pharma. Aark claims to provide 100% authentic, cold-chain managed medicines. Aark supplies a wide range of Astellas Pharma products, including advanced cancer treatments.
The company serves hospitals, clinics, and patients across India, including major cities like Bangalore, Surat, Kolkata, Indore, Nagpur, Patiala, Srinagar, Ahmedabad, Osmanabad, Mumbai, Pune, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Coimbatore, Kochi, Kollam, Agartala, Lucknow, Dehradun, Gairsain, Aizawal, Aurangabad, Barshi, Karungapally, Pondichery, Punjab, Delhi, New Delhi, Agra, Kanpur, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad, Wardha, Bhopal, Manipur, Mizoram, Sikkim, Tripura, Arunachal, Meghalaya, Nagaland, Pasighat, Cachar, Dibrugarh, Kamrup.
How much do Xospata Tablets cost in Delhi, India?
Prices may vary based on your prescribed treatment plan. For accurate and the most cost-effective pricing on your prescription-recommended product, please contact Aark Pharmaceuticals
Contact Person: Ms. Himanshi
Address: S-14, Ground & Ist Floor, Green Park Extn., New Delhi-110016.
Do you offer any discounts?
Yes. Based on availability, prices may vary based on your prescribed treatment plan. Please ask for the best current price.
Prior to consuming any medications, including Gilteritinib Tablet, it is advisable to seek guidance from a medical professional regarding its therapeutic advantages, usage instructions, and potential side effects.
NEWS / UPDATES
- FDA approves gilteritinib for relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation
- Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD–mutated AML.
- Antitumor activity of gilteritinib, an inhibitor of AXL, in human solid tumors.
- Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML.
- Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Written By
Mr. Sandeep Tomar (D. pharma)
Last updated
05 December 2025 | 10:10 AM (IST)
